Literature DB >> 21414113

Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic.

Hirotoshi Iihara1, Masashi Ishihara, Katsuhiko Matsuura, Sayoko Kurahashi, Takao Takahashi, Yoshihiro Kawaguchi, Kazuhiro Yoshida, Yoshinori Itoh.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: Outpatient cancer chemotherapy is increasing with the development of anticancer agents, and roles of medical staff are becoming more and more important in cancer chemotherapy. We showed here roles of pharmacists with experience in oncology and evaluated outcomes of their activities in medical practices in cancer chemotherapy clinic.
METHODS: Two pharmacists were newly assigned to the outpatient cancer chemotherapy clinic, where they were in charge of verification of prescription orders, mixing of anticancer injections, monitoring adverse drug reactions, implementation of supportive care and provision of information about cancer chemotherapy to medical staff and patients. The number of patients, amounts of mixing of anticancer injections and hospital revenue were compared before and after assignment of pharmacists. Management of chemotherapy-induced nausea and vomiting in breast cancer patients receiving the combination chemotherapy with anthracycline and cyclophosphamide were also compared.
RESULTS: Pharmacists spent 75 hours per month in patient education and adverse drug reactions monitoring, which led to the reduction of the workload of physicians. As a consequence, the number of outpatients and the resultant hospital revenue markedly increased. In addition, facilitation of proper use of anti-emetic drugs led to the improved control of chemotherapy-induced nausea with reducing the cost for anti-emesis by 16%.
CONCLUSIONS: Pharmacists contributed to the improved efficiency of medical practices.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414113     DOI: 10.1111/j.1365-2753.2011.01665.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  9 in total

Review 1.  The need for community pharmacists in oncology outpatient care: a systematic review.

Authors:  Johannes Thoma; Romána Zelkó; Balázs Hankó
Journal:  Int J Clin Pharm       Date:  2016-04-07

2.  A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan.

Authors:  Hirotoshi Iihara; Mototsugu Shimokawa; Toshinobu Hayashi; Hitoshi Kawazoe; Toshiaki Saeki; Keisuke Aiba; Kazuo Tamura
Journal:  Oncologist       Date:  2019-10-21

3.  Factors affecting the implementation of guideline-based prophylactic antiemetic therapy for chemotherapy-induced nausea and vomiting in Japan: a protocol for a hospital-based qualitative study.

Authors:  Akiko Yaguchi-Saito; Yuki Kaji; Ayumu Matsuoka; Ayako Okuyama; Maiko Fujimori; Junko Saito; Miyuki Odawara; Aki Otsuki; Yosuke Uchitomi; Sadamoto Zenda; Taichi Shimazu
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

Review 4.  The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue.

Authors:  Alan Carlotto; Virginia L Hogsett; Elyse M Maiorini; Janet G Razulis; Stephen T Sonis
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

5.  Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast Cancer.

Authors:  Kazuhide Tanaka; Akiyo Hori; Tomoya Tachi; Tomohiro Osawa; Katsuhiro Nagaya; Teppei Makino; Seiji Inoue; Masahiro Yasuda; Takashi Mizui; Takumi Nakada; Chitoshi Goto; Hitomi Teramachi
Journal:  J Pharm Health Care Sci       Date:  2018-04-30

6.  Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting.

Authors:  Natasha Khrystolubova; Monica Shieh; Anjan J Patel; Ray Bailey
Journal:  J Oncol Pharm Pract       Date:  2019-03-04       Impact factor: 1.809

7.  Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.

Authors:  Satoshi Dote; Shoji Itakura; Kohei Kamei; Daiki Hira; Satoshi Noda; Yuka Kobayashi; Tomohiro Terada
Journal:  BMC Cancer       Date:  2018-10-05       Impact factor: 4.430

8.  A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin-Based Chemotherapy-Induced Nausea and Vomiting in Japan.

Authors:  Hirotoshi Iihara; Mototsugu Shimokawa; Toshinobu Hayashi; Hitoshi Kawazoe; Toshiaki Saeki; Keisuke Aiba; Kazuo Tamura
Journal:  Oncologist       Date:  2019-10-21

9.  Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy.

Authors:  Chiemi Hirose; Hironori Fujii; Hirotoshi Iihara; Masashi Ishihara; Minako Nawa-Nishigaki; Hiroko Kato-Hayashi; Koichi Ohata; Kumiko Sekiya; Mika Kitahora; Nobuhisa Matsuhashi; Takao Takahashi; Kumiko Okuda; Masayo Naruse; Takuma Ishihara; Tadashi Sugiyama; Kazuhiro Yoshida; Akio Suzuki
Journal:  Support Care Cancer       Date:  2020-04-12       Impact factor: 3.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.